View:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
AUGUST 25, 1997
---------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------- ------- ----------
(State or other (Commission (IRS Employer
jurisdiction or File Number) Identification
organization) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
--------------------------------------------------------
(Address of principal executive offices)
910-229-1127
------------
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
On August 25, 1997, the Company issued a press release announcing that its
Board of Directors has declared dividends on the Company's 8 1/2% Series A
Convertible Exchangeable Preferred Stock and the Company's 8 1/2% Series B
Covertible Pay-in-Kind Preferred Stock.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibits
20 Press release of the Registrant dated August 25, 1997.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
(Registrant)
By:/s/ BRADFORD T. SMITH
--------------------------------
Bradford T. Smith
Executive Vice President,
General Counsel, Secretary
and Compliance Officer
Date: August 26, 1997
FOR IMMEDIATE RELEASE
Contact: Pamela Sherry
910-584-5171, Ext.4855
LABORATORY CORPORATION OF AMERICA-TM- DECLARES
PREFERRED STOCK DIVIDENDS
BURLINGTON, NC, AUGUST 25, 1997 _ Laboratory Corporation of America-TM-
Holdings (LabCorp-TM-) (NYSE: LH) today announced that its Board of
Directors has declared a dividend of $1.18056 per share on the Company's
8 1/2% Series A Convertible Exchangeable Preferred Stock (Series A Preferred
Stock), payable in cash. The Board has also declared a dividend of $1.18056
per share on the Company's 8 1/2% Series B Convertible Pay-in-Kind Preferred
Stock (Series B Preferred Stock), payable in shares of Series B Preferred
Stock at the rate of 0.02361 shares per share of Series B Preferred Stock
held. No fractional shares of Series B Preferred Stock will be issued, so
that the number of shares to be paid as a dividend on the Series B Preferred
Stock will be rounded to the nearest whole number of shares. The dividends
will be payable on September 30, 1997 for each issued and outstanding share
of Series A and B Preferred Stock to stockholders of record on September 19,
1997, and will cover the dividend period from the date of issuance to
September 30, 1997 at an equivalent annualized rate of $4.25 per share.
Laboratory Corporation of America-TM- Holdings (LabCorp-TM-) is a national
clinical laboratory organization with revenues of $1.6 billion in 1996. The
Company operates primary testing facilities nationally, offering more than
1,700 different clinical assays, from routine blood analysis to more
sophisticated technologies. LabCorp performs diagnostic tests for
physicians, managed care organizations, hospitals, clinics, long-term care
facilities, industrial companies and other clinical laboratories.